SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: The mean SKP2 gene expression levels were significantly higher in the CML patients compared to the control group (2.3 ± 0.9 vs. 0.8 ± 0.3 (p < 0.001)) (Table 1, Figure 1).